The BIFLUIX brand, founded in 2010 (Switzerland), from 2951 sister brands and 17477 competing brands. BIFLUIX is owned by NOVARTIS N, listed on the stock exchange of Zurich The ISIN, the company's International Securities Identification Number, is CH0012005267. BIFLUIX belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(BIFLUIX)
over 5 years*
CHF 102.45